Weight-loss drugs – a global market expected to reach $150bn by 2035 (Morgan Stanley, 2025) – are driving shifts in aesthetic ideals in tandem with new aesthetic concerns. From side-effect skincare to ‘Ozempic face’ tweakments and new categories of supportive supplements, we chart the commercial opportunities across the beauty and wellness sectors.